{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:55:47Z","timestamp":1792518947130,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s12035-024-04309-y","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T15:04:21Z","timestamp":1719414261000},"page":"846-860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["NEAT1 Promotes Valproic Acid-Induced Autism Spectrum Disorder by Recruiting YY1 to Regulate UBE3A Transcription"],"prefix":"10.1007","volume":"62","author":[{"given":"Chuping","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"4309_CR1","doi-asserted-by":"publisher","unstructured":"Genovese A, Butler MG (2020) Clinical assessment, genetics, and treatment approaches in autism spectrum disorder (ASD). Int J Mol Sci 21(13):4726. https:\/\/doi.org\/10.3390\/ijms21134726","DOI":"10.3390\/ijms21134726"},{"issue":"6","key":"4309_CR2","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ridd.2010.06.002","volume":"31","author":"C Gillberg","year":"2010","unstructured":"Gillberg C (2010) The ESSENCE in child psychiatry: early symptomatic syndromes eliciting neurodevelopmental clinical examinations. Res Dev Disabil 31(6):1543\u20131551","journal-title":"Res Dev Disabil"},{"issue":"4","key":"4309_CR3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(13)70011-5","volume":"12","author":"A Moreno-De-Luca","year":"2013","unstructured":"Moreno-De-Luca A et al (2013) Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence. Lancet Neurol 12(4):406\u2013414","journal-title":"Lancet Neurol"},{"issue":"11","key":"4309_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7011a1","volume":"70","author":"MJ Maenner","year":"2021","unstructured":"Maenner MJ et al (2021) Prevalence and characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2018. MMWR Surveill Summ 70(11):1\u201316","journal-title":"MMWR Surveill Summ"},{"issue":"11","key":"4309_CR5","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1007\/s10803-020-04537-w","volume":"50","author":"C Solomon","year":"2020","unstructured":"Solomon C (2020) Autism and employment: implications for employers and adults with ASD. J Autism Dev Disord 50(11):4209\u20134217","journal-title":"J Autism Dev Disord"},{"key":"4309_CR6","doi-asserted-by":"publisher","unstructured":"Wang L, Wang B, Wu C, Wang J, Sun M (2023) Autism spectrum disorder: neurodevelopmental risk factors, biological mechanism, and precision therapy. Int J Mol Sci 24(3):1819. https:\/\/doi.org\/10.3390\/ijms24031819","DOI":"10.3390\/ijms24031819"},{"issue":"6","key":"4309_CR7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","volume":"84","author":"RL Bromley","year":"2013","unstructured":"Bromley RL et al (2013) The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 84(6):637\u2013643","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt A","key":"4309_CR8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","volume":"299","author":"C Nicolini","year":"2018","unstructured":"Nicolini C, Fahnestock M (2018) The valproic acid-induced rodent model of autism. Exp Neurol 299(Pt A):217\u2013227","journal-title":"Exp Neurol"},{"key":"4309_CR9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fncel.2018.00422","volume":"12","author":"HY Kuo","year":"2018","unstructured":"Kuo HY, Liu FC (2018) Molecular pathology and pharmacological treatment of autism spectrum disorder-like phenotypes using rodent models. Front Cell Neurosci 12:422","journal-title":"Front Cell Neurosci"},{"key":"4309_CR10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1146\/annurev-cellbio-100814-125353","volume":"31","author":"S Lodato","year":"2015","unstructured":"Lodato S, Arlotta P (2015) Generating neuronal diversity in the mammalian cerebral cortex. Annu Rev Cell Dev Biol 31:699\u2013720","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"23","key":"4309_CR11","doi-asserted-by":"crossref","first-page":"R1116","DOI":"10.1016\/j.cub.2015.10.049","volume":"25","author":"JJ Knierim","year":"2015","unstructured":"Knierim JJ (2015) The hippocampus. Curr Biol 25(23):R1116\u2013R1121","journal-title":"Curr Biol"},{"key":"4309_CR12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pneurobio.2018.09.004","volume":"171","author":"ET Rolls","year":"2018","unstructured":"Rolls ET, Wirth S (2018) Spatial representations in the primate hippocampus, and their functions in memory and navigation. Prog Neurobiol 171:90\u2013113","journal-title":"Prog Neurobiol"},{"key":"4309_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000356422","volume":"34","author":"B Opitz","year":"2014","unstructured":"Opitz B (2014) Memory function and the hippocampus. Front Neurol Neurosci 34:51\u201359","journal-title":"Front Neurol Neurosci"},{"issue":"1","key":"4309_CR14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/nyas.13006","volume":"1369","author":"S Sheldon","year":"2016","unstructured":"Sheldon S, Levine B (2016) The role of the hippocampus in memory and mental construction. Ann N Y Acad Sci 1369(1):76\u201392","journal-title":"Ann N Y Acad Sci"},{"key":"4309_CR15","doi-asserted-by":"publisher","unstructured":"Ayabe T et al (2019) The lacto-tetrapeptide gly-Thr-Trp-Tyr, \u03b2-Lactolin, improves spatial memory functions via dopamine release and D1 receptor activation in the hippocampus. Nutrients 11(10):2469. https:\/\/doi.org\/10.3390\/nu11102469","DOI":"10.3390\/nu11102469"},{"issue":"6","key":"4309_CR16","doi-asserted-by":"crossref","first-page":"066013","DOI":"10.1088\/1741-2560\/10\/6\/066013","volume":"10","author":"RE Hampson","year":"2013","unstructured":"Hampson RE et al (2013) Facilitation of memory encoding in primate hippocampus by a neuroprosthesis that promotes task-specific neural firing. J Neural Eng 10(6):066013","journal-title":"J Neural Eng"},{"issue":"10","key":"4309_CR17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.tins.2021.08.005","volume":"44","author":"SM Banker","year":"2021","unstructured":"Banker SM et al (2021) Hippocampal contributions to social and cognitive deficits in autism spectrum disorder. Trends Neurosci 44(10):793\u2013807","journal-title":"Trends Neurosci"},{"issue":"2","key":"4309_CR18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.neuron.2018.10.002","volume":"100","author":"TEJ Behrens","year":"2018","unstructured":"Behrens TEJ et al (2018) What is a cognitive map? Organizing knowledge for flexible behavior. Neuron 100(2):490\u2013509","journal-title":"Neuron"},{"issue":"9","key":"4309_CR19","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jaac.2019.08.008","volume":"59","author":"VP Reinhardt","year":"2020","unstructured":"Reinhardt VP et al (2020) Understanding hippocampal development in young children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 59(9):1069\u20131079","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"4309_CR20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L et al (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22(2):96\u2013118","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"4309_CR21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS et al (2023) Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24(6):430\u2013447","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"4309_CR22","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/gb-2010-11-7-r72","volume":"11","author":"RA Chodroff","year":"2010","unstructured":"Chodroff RA et al (2010) Long noncoding RNA genes: conservation of sequence and brain expression among diverse amniotes. Genome Biol 11(7):R72","journal-title":"Genome Biol"},{"issue":"7","key":"4309_CR23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2741\/4776","volume":"24","author":"S Oe","year":"2019","unstructured":"Oe S, Kimura T, Yamada H (2019) Regulatory non-coding RNAs in nervous system development and disease. Front Biosci (Landmark Ed) 24(7):1203\u20131240","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"8","key":"4309_CR24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/cns.12710","volume":"23","author":"J Tang","year":"2017","unstructured":"Tang J, Yu Y, Yang W (2017) Long noncoding RNA and its contribution to autism spectrum disorders. CNS Neurosci Ther 23(8):645\u2013656","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"4309_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12031-021-01934-3","volume":"72","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S et al (2022) Emerging role of non-coding RNAs in autism spectrum disorder. J Mol Neurosci 72(2):201\u2013216","journal-title":"J Mol Neurosci"},{"key":"4309_CR26","doi-asserted-by":"crossref","first-page":"136726","DOI":"10.1016\/j.neulet.2022.136726","volume":"783","author":"X Liu","year":"2022","unstructured":"Liu X et al (2022) LncRNA MEG3 activates CDH2 expression by recruitment of EP300 in valproic acid-induced autism spectrum disorder. Neurosci Lett 783:136726","journal-title":"Neurosci Lett"},{"key":"4309_CR27","doi-asserted-by":"publisher","unstructured":"Jiang M, Chen G (2023) Investigation of LncRNA PVT1 and MiR-21-5p expression as promising novel biomarkers for autism spectrum disorder. J Mol Neurosci 73(9\u201310):865-873. https:\/\/doi.org\/10.1007\/s12031-023-02161-8","DOI":"10.1007\/s12031-023-02161-8"},{"issue":"12","key":"4309_CR28","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/aur.2413","volume":"13","author":"T Luo","year":"2020","unstructured":"Luo T et al (2020) The autism-related lncRNA MSNP1AS regulates moesin protein to influence the RhoA, Rac1, and PI3K\/Akt pathways and regulate the structure and survival of neurons. Autism Res 13(12):2073\u20132082","journal-title":"Autism Res"},{"key":"4309_CR29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fgene.2018.00471","volume":"9","author":"P Dong","year":"2018","unstructured":"Dong P et al (2018) Long non-coding rNA NEAT1: a novel target for diagnosis and therapy in human tumors. Front Genet 9:471","journal-title":"Front Genet"},{"issue":"10","key":"4309_CR30","doi-asserted-by":"crossref","first-page":"11223","DOI":"10.1096\/fj.201900830R","volume":"33","author":"A Simchovitz","year":"2019","unstructured":"Simchovitz A et al (2019) NEAT1 is overexpressed in Parkinson\u2019s disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress. FASEB J 33(10):11223\u201311234","journal-title":"FASEB J"},{"issue":"7","key":"4309_CR31","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3349\/ymj.2019.60.7.640","volume":"60","author":"S Ke","year":"2019","unstructured":"Ke S et al (2019) Long noncoding RNA NEAT1 aggravates A\u03b2-induced neuronal damage by targeting miR-107 in Alzheimer\u2019s disease. Yonsei Med J 60(7):640\u2013650","journal-title":"Yonsei Med J"},{"key":"4309_CR32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s12035-016-9928-9","volume":"54","author":"J-S Sunwoo","year":"2017","unstructured":"Sunwoo J-S et al (2017) Altered expression of the long noncoding RNA NEAT1 in Huntington\u2019s disease. Mol Neurobiol 54:1577\u20131586","journal-title":"Mol Neurobiol"},{"issue":"10","key":"4309_CR33","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1080\/15476286.2018.1534524","volume":"15","author":"K Chanda","year":"2018","unstructured":"Chanda K et al (2018) Altered levels of long ncRNAs Meg3 and Neat1 in cell and animal models of Huntington\u2019s disease. RNA Biol 15(10):1348\u20131363","journal-title":"RNA Biol"},{"issue":"2","key":"4309_CR34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12031-018-1240-x","volume":"67","author":"A Sayad","year":"2019","unstructured":"Sayad A et al (2019) Aberrant expression of long non-coding RNAs in peripheral blood of autistic patients. J Mol Neurosci 67(2):276\u2013281","journal-title":"J Mol Neurosci"},{"key":"4309_CR35","doi-asserted-by":"crossref","first-page":"109328","DOI":"10.1016\/j.cellsig.2019.05.013","volume":"62","author":"W Yao","year":"2019","unstructured":"Yao W, Huang J, He H (2019) Over-expressed LOC101927196 suppressed oxidative stress levels and neuron cell proliferation in a rat model of autism through disrupting the Wnt signaling pathway by targeting FZD3. Cell Signal 62:109328","journal-title":"Cell Signal"},{"issue":"6","key":"4309_CR36","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/fcp.12567","volume":"34","author":"IO Ishola","year":"2020","unstructured":"Ishola IO, Balogun AO, Adeyemi OO (2020) Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system. Fundam Clin Pharmacol 34(6):650\u2013661","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"4309_CR37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11011-016-9902-2","volume":"32","author":"IO Ishola","year":"2017","unstructured":"Ishola IO, Adamson FM, Adeyemi OO (2017) Ameliorative effect of kolaviron, a biflavonoid complex from Garcinia kola seeds against scopolamine-induced memory impairment in rats: role of antioxidant defense system. Metab Brain Dis 32(1):235\u2013245","journal-title":"Metab Brain Dis"},{"issue":"1","key":"4309_CR38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/cr.2017.132","volume":"28","author":"X Xu","year":"2018","unstructured":"Xu X et al (2018) Excessive UBE3A dosage impairs retinoic acid signaling and synaptic plasticity in autism spectrum disorders. Cell Res 28(1):48\u201368","journal-title":"Cell Res"},{"issue":"1","key":"4309_CR39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/diseases12010007","volume":"12","author":"B Roy","year":"2024","unstructured":"Roy B et al (2024) UBE3A: The role in autism spectrum disorders (ASDs) and a potential candidate for biomarker studies and designing therapeutic strategies. Diseases 12(1):7","journal-title":"Diseases"},{"issue":"1","key":"4309_CR40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nic.2019.09.009","volume":"30","author":"JB Girault","year":"2020","unstructured":"Girault JB, Piven J (2020) The neurodevelopment of autism from infancy through toddlerhood. Neuroimaging Clin N Am 30(1):97\u2013114","journal-title":"Neuroimaging Clin N Am"},{"key":"4309_CR41","doi-asserted-by":"publisher","unstructured":"Beopoulos A, G\u00e9a M, Fasano A, Iris F (2022) Autism spectrum disorders pathogenesis: toward a comprehensive model based on neuroanatomic and neurodevelopment considerations. Front Neurosci 16:988735. https:\/\/doi.org\/10.3389\/fnins.2022.988735","DOI":"10.3389\/fnins.2022.988735"},{"issue":"5","key":"4309_CR42","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tins.2020.03.005","volume":"43","author":"E Courchesne","year":"2020","unstructured":"Courchesne E, Gazestani VH, Lewis NE (2020) Prenatal origins of ASD: the when, what, and how of ASD development. Trends Neurosci 43(5):326\u2013342","journal-title":"Trends Neurosci"},{"issue":"1","key":"4309_CR43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13229-021-00428-8","volume":"12","author":"ME Traetta","year":"2021","unstructured":"Traetta ME et al (2021) Hippocampal neurons isolated from rats subjected to the valproic acid model mimic in vivo synaptic pattern: evidence of neuronal priming during early development in autism spectrum disorders. Mol Autism 12(1):23","journal-title":"Mol Autism"},{"issue":"11","key":"4309_CR44","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/aur.2597","volume":"14","author":"K Luhach","year":"2021","unstructured":"Luhach K et al (2021) Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress. Autism Res 14(11):2270\u20132286","journal-title":"Autism Res"},{"key":"4309_CR45","doi-asserted-by":"crossref","first-page":"109885","DOI":"10.1016\/j.intimp.2023.109885","volume":"117","author":"Y Xiong","year":"2023","unstructured":"Xiong Y et al (2023) Thymol improves autism-like behaviour in VPA-induced ASD rats through the Pin1\/p38 MAPK pathway. Int Immunopharmacol 117:109885","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"4309_CR46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00401-017-1736-4","volume":"134","author":"M Varghese","year":"2017","unstructured":"Varghese M et al (2017) Autism spectrum disorder: neuropathology and animal models. Acta Neuropathol 134(4):537\u2013566","journal-title":"Acta Neuropathol"},{"issue":"1","key":"4309_CR47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41398-022-01875-4","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang L et al (2022) Progranulin improves neural development via the PI3K\/Akt\/GSK-3\u03b2 pathway in the cerebellum of a VPA-induced rat model of ASD. Transl Psychiatry 12(1):114","journal-title":"Transl Psychiatry"},{"issue":"1","key":"4309_CR48","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0031512517743823","volume":"125","author":"CVA Toscano","year":"2018","unstructured":"Toscano CVA, Carvalho HM, Ferreira JP (2018) Exercise effects for children with autism spectrum disorder: metabolic health, autistic traits, and quality of life. Percept Mot Skills 125(1):126\u2013146","journal-title":"Percept Mot Skills"},{"key":"4309_CR49","doi-asserted-by":"publisher","unstructured":"Siniscalco D, Schultz S, Brigida AL, Antonucci N (2018) Inflammation and neuro-immune dysregulations in autism spectrum disorders. Pharmaceuticals (Basel) 11(2):56. https:\/\/doi.org\/10.3390\/ph11020056","DOI":"10.3390\/ph11020056"},{"issue":"1","key":"4309_CR50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","volume":"25","author":"P Ashwood","year":"2011","unstructured":"Ashwood P et al (2011) Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25(1):40\u201345","journal-title":"Brain Behav Immun"},{"issue":"4","key":"4309_CR51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/bs6040029","volume":"6","author":"MC Inga J\u00e1come","year":"2016","unstructured":"Inga J\u00e1come MC et al (2016) Peripheral inflammatory markers contributing to comorbidities in autism. Behav Sci 6(4):29","journal-title":"Behav Sci"},{"key":"4309_CR52","doi-asserted-by":"publisher","unstructured":"Pangrazzi L, Balasco L, Bozzi Y (2020) Oxidative stress and immune system dysfunction in autism spectrum disorders. Int J Mol Sci 21(9):3293. https:\/\/doi.org\/10.3390\/ijms21093293","DOI":"10.3390\/ijms21093293"},{"issue":"1","key":"4309_CR53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41398-020-01135-3","volume":"11","author":"L Chen","year":"2021","unstructured":"Chen L et al (2021) Oxidative stress marker aberrations in children with autism spectrum disorder: a systematic review and meta-analysis of 87 studies (N = 9109). Transl Psychiatry 11(1):15","journal-title":"Transl Psychiatry"},{"key":"4309_CR54","doi-asserted-by":"publisher","unstructured":"Saceleanu VM, Toader C, Ples H, Covache-Busuioc RA, Costin HP, Bratu BG, Dumitrascu DI, Bordeianu A, Corlatescu AD, Ciurea AV (2023) Integrative approaches in acute ischemic stroke: from symptom recognition to future innovations. Biomedicines 11(10):2617. https:\/\/doi.org\/10.3390\/biomedicines11102617","DOI":"10.3390\/biomedicines11102617"},{"key":"4309_CR55","doi-asserted-by":"publisher","unstructured":"Singh R, Kisku A, Kungumaraj H, Nagaraj V, Pal A, Kumar S, Sulakhiya K (2023) Autism spectrum disorders: a recent update on targeting inflammatory pathways with natural anti-inflammatory agents. Biomedicines 11(1):115. https:\/\/doi.org\/10.3390\/biomedicines11010115","DOI":"10.3390\/biomedicines11010115"},{"issue":"3","key":"4309_CR56","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1007\/s12035-022-02738-1","volume":"59","author":"XB Wei","year":"2022","unstructured":"Wei XB et al (2022) Exosome-derived lncRNA NEAT1 exacerbates sepsis-associated encephalopathy by promoting ferroptosis through regulating miR-9-5p\/TFRC and GOT1 Axis. Mol Neurobiol 59(3):1954\u20131969","journal-title":"Mol Neurobiol"},{"key":"4309_CR57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuroscience.2023.02.016","volume":"529","author":"Y Li","year":"2023","unstructured":"Li Y et al (2023) Targeting lncRNA NEAT1 hampers Alzheimer\u2019s disease progression. Neuroscience 529:88\u201398","journal-title":"Neuroscience"},{"issue":"4","key":"4309_CR58","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbrc.2017.12.149","volume":"496","author":"W Yan","year":"2018","unstructured":"Yan W et al (2018) LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson\u2019s disease through stabilizing PINK1 protein. Biochem Biophys Res Commun 496(4):1019\u20131024","journal-title":"Biochem Biophys Res Commun"},{"key":"4309_CR59","doi-asserted-by":"crossref","first-page":"147921","DOI":"10.1016\/j.brainres.2022.147921","volume":"1788","author":"Z Zhou","year":"2022","unstructured":"Zhou Z et al (2022) LncRNA NEAT1 stabilized Wnt3a via U2AF2 and activated Wnt\/\u03b2-catenin pathway to alleviate ischemia stroke induced injury. Brain Res 1788:147921","journal-title":"Brain Res"},{"issue":"9","key":"4309_CR60","doi-asserted-by":"crossref","first-page":"e1418","DOI":"10.1002\/ctm2.1418","volume":"13","author":"D Chen","year":"2023","unstructured":"Chen D et al (2023) LncRNA NEAT1 suppresses cellular senescence in hepatocellular carcinoma via KIF11-dependent repression of CDKN2A. Clin Transl Med 13(9):e1418","journal-title":"Clin Transl Med"},{"issue":"1","key":"4309_CR61","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13046-022-02449-4","volume":"41","author":"Y Jia","year":"2022","unstructured":"Jia Y et al (2022) Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun\/c-Fos\/SREBP1 axis in gastric cancer. J Exp Clin Cancer Res 41(1):287","journal-title":"J Exp Clin Cancer Res"},{"key":"4309_CR62","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mam.2019.07.004","volume":"70","author":"E Hosseini","year":"2019","unstructured":"Hosseini E et al (2019) The importance of long non-coding RNAs in neuropsychiatric disorders. Mol Aspects Med 70:127\u2013140","journal-title":"Mol Aspects Med"},{"issue":"11","key":"4309_CR63","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41419-023-06311-z","volume":"14","author":"S Wang","year":"2023","unstructured":"Wang S et al (2023) LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex. Cell Death Dis 14(11):767","journal-title":"Cell Death Dis"},{"issue":"12","key":"4309_CR64","doi-asserted-by":"crossref","first-page":"e23288","DOI":"10.1096\/fj.202301070RR","volume":"37","author":"Y Cao","year":"2023","unstructured":"Cao Y et al (2023) LINC02454 promotes thyroid carcinoma progression via upregulating HMGA2 through CREB1. Faseb J 37(12):e23288","journal-title":"Faseb J"},{"issue":"9","key":"4309_CR65","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1007\/s11064-023-03944-6","volume":"48","author":"Y Zhou","year":"2023","unstructured":"Zhou Y et al (2023) LncRNA NKILA exacerbates Alzheimer\u2019s disease progression by regulating the FOXA1-mediated transcription of TNFAIP1. Neurochem Res 48(9):2895\u20132910","journal-title":"Neurochem Res"},{"key":"4309_CR66","doi-asserted-by":"publisher","unstructured":"Rahman MR, Petralia MC, Ciurleo R, Bramanti A, Fagone P, Shahjaman M, Wu L, Sun Y, Turanli B, Arga KY, Islam MR, Islam T, Nicoletti F (2020) Comprehensive analysis of rna-seq gene expression profiling of brain transcriptomes reveals novel genes, regulators, and pathways in autism spectrum disorder. Brain Sci 10(10):747. https:\/\/doi.org\/10.3390\/brainsci10100747","DOI":"10.3390\/brainsci10100747"},{"key":"4309_CR67","doi-asserted-by":"crossref","first-page":"592164","DOI":"10.3389\/fcell.2020.592164","volume":"8","author":"TC Verheul","year":"2020","unstructured":"Verheul TC et al (2020) The why of YY1: mechanisms of transcriptional regulation by Yin Yang 1. Front Cell Dev Biol 8:592164","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4309_CR68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-018-0394-7","volume":"10","author":"DM Vargas","year":"2018","unstructured":"Vargas DM et al (2018) Alzheimer\u2019s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates. Alzheimer\u2019s Res Ther 10(1):59","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"16","key":"4309_CR69","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/hmg\/ddq214","volume":"19","author":"G Forlani","year":"2010","unstructured":"Forlani G et al (2010) The MeCP2\/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis. Hum Mol Genet 19(16):3114\u20133123","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4309_CR70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.31887\/DCNS.2017.19.1\/rpal","volume":"19","author":"PC Tiwari","year":"2017","unstructured":"Tiwari PC, Pal R (2017) The potential role of neuroinflammation and transcription factors in Parkinson disease. Dialogues Clin Neurosci 19(1):71\u201380","journal-title":"Dialogues Clin Neurosci"},{"issue":"3","key":"4309_CR71","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/jnc.15594","volume":"161","author":"S Pabian-Jewu\u0142a","year":"2022","unstructured":"Pabian-Jewu\u0142a S, Bragiel-Pieczonka A, Rylski M (2022) Ying Yang 1 engagement in brain pathology. J Neurochem 161(3):236\u2013253","journal-title":"J Neurochem"},{"key":"4309_CR72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12031-019-01456-z","volume":"70","author":"J Jiao","year":"2020","unstructured":"Jiao J et al (2020) Identification of de novo JAK2 and MAPK7 mutations related to autism spectrum disorder using whole-exome sequencing in a Chinese child and adolescent trio-based sample. J Mol Neurosci 70:219\u2013229","journal-title":"J Mol Neurosci"},{"issue":"10","key":"4309_CR73","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/brainsci10100747","volume":"10","author":"MR Rahman","year":"2020","unstructured":"Rahman MR et al (2020) Comprehensive analysis of RNA-seq gene expression profiling of brain transcriptomes reveals novel genes, regulators, and pathways in autism spectrum disorder. Brain Sci 10(10):747","journal-title":"Brain Sci"},{"issue":"11","key":"4309_CR74","doi-asserted-by":"crossref","first-page":"e1481","DOI":"10.1002\/mgg3.1481","volume":"8","author":"A Geerts-Haages","year":"2020","unstructured":"Geerts-Haages A et al (2020) A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome. Mol Genet Genomic Med 8(11):e1481","journal-title":"Mol Genet Genomic Med"},{"issue":"25","key":"4309_CR75","doi-asserted-by":"crossref","first-page":"12500","DOI":"10.1073\/pnas.1820131116","volume":"116","author":"J Wang","year":"2019","unstructured":"Wang J et al (2019) UBE3A-mediated PTPA ubiquitination and degradation regulate PP2A activity and dendritic spine morphology. Proc Natl Acad Sci U S A 116(25):12500\u201312505","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04309-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04309-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04309-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T22:09:49Z","timestamp":1736374189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04309-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4309"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04309-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"assertion":[{"value":"8 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal-related procedures were carried out in accordance with the ARRIVE guidelines, and this study was approved by the Ethics Committee of the Chenzhou First People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}